Muscarinic Receptors and Alzheimer's Disease: New Perspectives and Mechanisms

被引:2
|
作者
Monaco, Martina [1 ]
Trebesova, Hanna [1 ]
Grilli, Massimo [1 ,2 ]
机构
[1] Univ Genoa, Dept Pharm, Viale Cembrano 4, I-16148 Genoa, Italy
[2] Interuniv Ctr Promot 3Rs Principles Teaching & Res, I-16148 Genoa, Italy
关键词
Alzheimer's disease; muscarinic receptors; cholinergic transmission; neuroinflammation; innovative therapy; ACETYLCHOLINE-RECEPTOR; BINDING; DEFICITS; AGONIST; MEMORY; MODEL; NEUROINFLAMMATION; EXPRESSION; AROUSAL; PROTEIN;
D O I
10.3390/cimb46070407
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Alzheimer's disease (AD) is one of the most prevalent neurodegenerative diseases on a global scale. Historically, this pathology has been linked to cholinergic transmission, and despite the scarcity of effective therapies, numerous alternative processes and targets have been proposed as potential avenues for comprehending this complex illness. Nevertheless, the fundamental pathophysiological mechanisms underpinning AD remain largely enigmatic, with a growing body of evidence advocating for the significance of muscarinic receptors in modulating the brain's capacity to adapt and generate new memories. This review summarizes the current state of the art in the field of muscarinic receptors' involvement in AD. A specific key factor was the relationship between comorbidity and the emergence of new mechanisms.
引用
收藏
页码:6820 / 6835
页数:16
相关论文
共 50 条
  • [1] On the physiological relevance of muscarinic acetylcholine receptors in Alzheimer's disease
    Koch, HJ
    Haas, S
    Jürgens, T
    CURRENT MEDICINAL CHEMISTRY, 2005, 12 (24) : 2915 - 2921
  • [2] Designing Hybrids Targeting the Cholinergic System by Modulating the Muscarinic and Nicotinic Receptors: A Concept to Treat Alzheimer's Disease
    Volpato, Daniela
    Holzgrabe, Ulrike
    MOLECULES, 2018, 23 (12):
  • [3] Infection and inflammation: New perspectives on Alzheimer's disease
    Whitson, Heather E.
    Colton, Carol
    El Khoury, Joseph
    Gate, David
    Goate, Alison
    Heneka, Michael T.
    Kaddurah-Daouk, Rima
    Klein, Robyn S.
    Shinohara, Mari L.
    Sisodia, Sangram
    Spudich, Serena S.
    Stevens, Beth
    Tanzi, Rudolph
    Ting, Jenny P.
    Garden, Gwenn
    BRAIN BEHAVIOR & IMMUNITY-HEALTH, 2022, 22
  • [4] Mechanisms of abnormal adult hippocampal neurogenesis in Alzheimer's disease
    Zhou, Yujuan
    Wang, Xu
    Liu, Yingying
    Gu, Yulu
    Gu, Renjun
    Zhang, Geng
    Lin, Qing
    FRONTIERS IN NEUROSCIENCE, 2023, 17
  • [5] Imaging of nicotinic and muscarinic receptors in Alzheimer's disease: Effect of tacrine treatment
    Nordberg, A
    Lundqvist, H
    Hartvig, P
    Andersson, J
    Johansson, M
    HellstromLindahl, E
    Langstrom, B
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 1997, 8 (02) : 78 - 84
  • [6] Microglia Polarization in Alzheimer's Disease: Mechanisms and a Potential Therapeutic Target
    Wang, Qinqin
    Yao, Hongmei
    Liu, Wenyan
    Ya, Bailiu
    Cheng, Hongju
    Xing, Zhenkai
    Wu, Yili
    FRONTIERS IN AGING NEUROSCIENCE, 2021, 13
  • [7] Perspectives on the amyloid cascade hypothesis of Alzheimer's disease
    Simon, Ana M.
    Frechilla, Diana
    del Rio, Joaquin
    REVISTA DE NEUROLOGIA, 2010, 50 (11) : 667 - 675
  • [8] Muscarinic agonists in Alzheimer's disease
    Growdon, JH
    LIFE SCIENCES, 1997, 60 (13-14) : 993 - 998
  • [9] Molecular Mechanisms of Synaptotoxicity and Neuroinflammation in Alzheimer's Disease
    Marttinen, Mikael
    Takalo, Mari
    Natunen, Teemu
    Wittrahm, Rebekka
    Gabbouj, Sami
    Kemppainen, Susanna
    Leinonen, Ville
    Tanila, Heikki
    Haapasalo, Annakaisa
    Hiltunen, Mikko
    FRONTIERS IN NEUROSCIENCE, 2018, 12
  • [10] Antimicrobial therapy and the potential mechanisms in Alzheimer's disease
    Song, Xiaochen
    Chen, Jing
    Hou, Zhitao
    Xie, Ning
    NEUROSCIENCE LETTERS, 2021, 741